Navigation Links
Two New Human Papilloma virus (HPV) vaccines to prevent cervical cancer

Cervical cancer is the second leading cause of female cancer mortality worldwide, with 288,000 deaths annually. About 510,000 cases are // reported each year, 80% of them in developing countries.

Two new vaccines are undergoing trial to prevent HPV infections, which causes cervical cancer. These vaccines must be given to girls before they are sexually active. The new vaccines are manufactured by GlaxoSmithkline against HPV 16 and 18 strains and the Merck Vaccine against HPV 16,18,6 and 11. These vaccines carry the L capsid protein and when given in 3 doses generate high levels of neutralizing antibodies.

Both the drugs are safe and show an efficacy of more than 90% in Phase I and II trials. These both vaccines are in their phase III trial and are expected to be in market in an other 2 years.

Studies are currently undergoing to find the duration and efficacy of the vaccine, its effect on menstrual cycle and the need for booster vaccine. Problems with the new vaccine are due to high cost, the dosages required are three injections and creating a cold chain for transport to rural areas. This vaccine should be modified to give protection against more HPV types and must be cheaper and easier to administer.

Experts say though this vaccine may be effective for prevention of infection a better promising approach for developing countries would be to undergo a cheaper screening test and visual inspection followed by prevention and treatment.


'"/>




Page: 1

Related medicine news :

1. Human Genome Project Achieves Technological Triumph
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Human gene number increases
4. Scientists found ancient Human Germ Killer
5. New standards for Human Research Safety
6. Human wasting disease linked to a gene
7. The Human Mad Cow Case
8. Human Growth Hormone Found To be Dangerous For Human Use
9. Human Antibody That Can Block SARS
10. Human immunity system can battle HIV.
11. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... ... June 23, 2016 , ... Representatives of CHA Fertility Centers ... member of their staff, Dr. Joshua J. Berger. As of May 2016, Dr. ... world-renowned facility. , Dr. Berger has received recognition for his research, his teaching and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Horizon Blue Cross Blue Shield ... relief from the crushing burden of sky-high health care costs, Superior Court of ... ruling ( http://www.judiciary.state.nj.us/opinions/a2913-15a2929-15.pdf ) the court provided some analysis of the contracts ...
(Date:6/23/2016)... ... ... As part of an ongoing commitment to encourage living a healthy and ... BCBSNJ) have teamed up with New Jersey native and PGA Tour member Morgan Hoffmann ... lifestyle. , Through Healthy Steps NJ, Hoffmann will share a series of health education ...
(Date:6/23/2016)... ... ... A key metric of this success is the popularity of the Leafedin.org service ... areas that lack the kind of technology and networking framework that LeafedIn.org provide, where ... the marijuana industry, no matter how small or large, and more importantly no matter ...
(Date:6/23/2016)... ... June 23, 2016 , ... King Kullen’s Shop OnLine, the ... to yet another location: Garden City Park. This is the fourth store to be ... grocery delivery service is offered by King Kullen and allows customers to place orders ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: